menu
You are here
Press Releases
Untangling a cause of memory loss in neurodegenerative diseases
Tuesday, October 11, 2016
NIH-funded mouse study identifies a possible therapeutic target for a family of disorders
Targeting cardiovascular disease risk factors may be important across a lifetime
Wednesday, October 5, 2016
NIH-funded study suggests efforts to prevent risk factors should extend to those older than 65
Researchers find a gap in the brain’s firewall against Parkinson’s disease
Friday, September 30, 2016
NIH-funded mouse study identifies a key player in the progression of the disorder
“Sixth sense” may be more than just a feeling
Friday, September 23, 2016
NIH study of rare genetic disorder reveals importance of touch and body awareness
New members appointed to National Advisory Neurological Disorders and Stroke Council
Friday, September 16, 2016
Four distinguished individuals from the neuroscience community have been chosen to serve on the National Advisory Neurological Disorders and Stroke Council, the principal advisory body to the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Healt
NINDS Names Dr. Clinton B. Wright as Director of the Office of Clinical Research
Thursday, September 15, 2016
The National Institute of Neurological Disorders and Stroke (NINDS) has named vascular neurologist Clinton B. Wright, M.D., M.S., as director of its Office of Clinical Research (OCR) and associate director of the institute. Dr. Wright is expected to join the NINDS in November.
Stem cell therapy heals injured mouse brain
Monday, August 22, 2016
Animal study examines method for restoring brain cells killed by stroke or other neurological diseases
Researchers examine how Parkinson’s disease alters brain activity over time
Monday, August 15, 2016
Tracking neural changes could help researchers test therapies that slow disease progression
NIH-funded study supports surgery as treatment for myasthenia gravis
Wednesday, August 10, 2016
In a global study of myasthenia gravis, an autoimmune disease that causes muscle weakness and fatigue, researchers found that surgical removal of an organ called the thymus reduced patients’ weakness, and their need for immunosuppressive drugs.